Intra-operative Optical Imaging With MDX1201-A488 in Patients With Prostate Cancer

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 5, 2015

Primary Completion Date

May 10, 2018

Study Completion Date

February 1, 2023

Conditions

Adenocarcinoma of the ProstateStage IIB Prostate CancerStage III Prostate CancerStage IV Prostate Cancer

Interventions

BIOLOGICAL

anti-PSMA monoclonal antibody MDX1201-A488

Given IV

PROCEDURE

robot-assisted laparoscopic surgery

Undergo RALP

OTHER

diffuse optical imaging

Undergo IOOI

OTHER

pharmacological study

Correlative studies

OTHER

Laboratory Biomarker

Correlative studies

OTHER

Questionnaire

Ancillary studies

Trial Locations (1)

City of Hope Medical Center, Duarte

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER

NCT02048150 - Intra-operative Optical Imaging With MDX1201-A488 in Patients With Prostate Cancer | Biotech Hunter | Biotech Hunter